Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Ribometrix Launches With $30 Million to Develop RNA Structure-Based Drugs

Durham, North Carolina-based Ribometrix closed on a Series A financing worth $30 million, led by M Ventures.

Read More »

Novartis plans for 60 regulatory filings during 2019-2021

Swiss pharma giant Novartis announced plans to seek regulatory approval for 60 new treatments between 2019 and 2021.

Read More »

India’s Dr. Reddy’s Q2 profit surges nearly 70 percent

Indian drugmaker Dr. Reddy’s Laboratories posted a 69.7 percent jump in fiscal second-quarter 2018 profit, helped by new product launches.

Read More »

Novartis to Launch Innovation Labs Across the Globe, Including Silicon Valley

To spur innovation and bolster ties with tech giants, Swiss pharma giant Novartis plans to set up innovation labs across the globe to partner with these companies to spur the development of new therapies.

Read More »

A Simple Checklist and a Little Yellow Box Transform Surgeries from Life-Threatening to Life-Saving Procedures Around the World

International non-profit organization Lifebox, in partnership with healthcare advertising agency precisioneffect, will launch the “Deadliest Conditions” campaign as the American College of Surgeons holds the 2018 Clinical Congress in Boston starting October 21st.

Read More »

GSK Funds New Startup with Immunometabolic Focus

Backed by GlaxoSmithKline and Boston’s SV Health Investors, a new biopharmaceutical company known as Sitryx launched with $30 million in a Series A funding round.

Read More »

Johnson & Johnson Vision Launches Worldwide Campaign to #SpotlightSight in Honor of World Sight Day

Johnson & Johnson Vision, a broad-based global leader in eye health, launched a worldwide campaign to #spotlightsight in honor of World Sight Day on October 11, 2018.

Read More »

U.S. FDA approves Lilly migraine drug; price same as rivals

The U.S. Food and Drug Administration approved Eli Lilly and Co.’s migraine drug Emgality, marking the third approval from a promising new class of treatments for the often debilitating headaches.

Read More »

EU approves fifth copy of AbbVie’s Humira

Europe approved a fifth copy of AbbVie’s $18-billion-a-year biologic Humira – the world’s best-selling prescription medicine – ramping up competition among makers of less-expensive biotech drugs.

Read More »

Healthcare Agency SFC Group Launches

SFC Group, a woman-owned, full-service, integrated communications agency, launched to serve the global pharmaceutical, life sciences, diagnostics and biotech industries.

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

October 2019 Focus: Top 50 Company Profiles & Financials, Outcomes Creativity Index, and more!

Subscribe

Ad Right Bottom